Quick Answer
VERACYTE, INC. reported Net Income Loss of $66.35 million for the year ending 2025.
- VERACYTE, INC. showed an increase of +174.9% in Net Income Loss from 2024 to 2025.
- This data is from VERACYTE, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: -$1.92 million | Q2 2019: -$2.49 million | Q3 2019: -$730.0 thousand | Q4 2019: -$7.46 million | Q1 2020: -$11.72 million | Q2 2020: -$11.03 million | Q3 2020: -$4.12 million | Q4 2020: -$8.04 million | Q1 2021: -$41.87 million | Q2 2021: -$9.04 million | Q3 2021: -$14.13 million | Q1 2022: -$14.46 million | Q2 2022: -$9.53 million | Q3 2022: -$8.72 million | Q1 2023: -$8.09 million | Q2 2023: -$8.40 million | Q3 2023: -$29.62 million | Q1 2024: -$1.86 million | Q2 2024: $5.73 million | Q3 2024: $15.16 million | Q1 2025: $7.05 million | Q2 2025: -$980.0 thousand | Q3 2025: $19.14 million.
- Over the full 8 years of available data (2018 to 2025), VERACYTE, INC.'s Net Income Loss has grown by 388.5%.
- Historical annual values: Fiscal year 2025: $66.35 million | Fiscal year 2024: $24.14 million | Fiscal year 2023: -$74.40 million | Fiscal year 2022: -$36.56 million | Fiscal year 2021: -$75.56 million | Fiscal year 2020: -$34.91 million | Fiscal year 2019: -$12.60 million | Fiscal year 2018: -$23.00 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: